glycogenesis 2 acid maltase deficiency
Showing 1 - 4 of 4
Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States
Terminated
- Pompe Disease
- +2 more
- Myozyme® (alglucosidase alfa)
-
Louisville, Kentucky
- +4 more
Mar 24, 2022
Pompe Disease (Late-Onset), Glycogen Storage Disease Type II (GSD II), Glycogenesis 2 Acid Maltase Deficiency Trial in Worldwide
Completed
- Pompe Disease (Late-Onset)
- +2 more
- Alglucosidase Alfa
-
Orange, California
- +14 more
Dec 4, 2014
Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Australia, Canada,
Completed
- Pompe Disease
- +2 more
- alglucosidase alfa
-
Birmingham, Alabama
- +10 more
Feb 4, 2014
Severe Late Onset Pompe Disease Pulmonary Dysfunction and
Completed
- Pompe Disease (Late-Onset)
- +2 more
-
Paris, FrancePitie-Salpetriere Hospital
Feb 4, 2014